ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 302325 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 302325; 2) Community: the network communities that were significantly associated with the response to NSC 302325; 3) Molecule: the relationships between components within communities and NSC 302325; 4) MDR: the compounds that were significantly associated with the NSC 302325.

NSC Compound Enrichment Correlation
NSC 740385 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide 0.0339770934764508 0.34891143
NSC 740504 5,6-Dihydro-6-[3-(2-hydroxyethyl)amino-1-propyl]-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0339770934764508 0.55231883
NSC 749292 3-methoxy-1-nitrosopyrido[3,2:4,5]pyrrolo[1,2-c][1,2,3]benzotriazine 0.0339770934764508 0.38035575
NSC 756166 GSK312948A 0.0339770934764508 0.54682016
NSC 757949 (1R,2E,6R,10E,11aS,13S,14aR)-6-(2-(benzyloxy)ethyl)-1,13-dihydroxy-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one 0.0339770934764508 -0.23571564
NSC 88054 Null 0.0339770934764508 0.33049505
NSC 105509 Null 0.0339770934764516 -0.11827663
NSC 125347 Null 0.0339770934764516 0.61627906
NSC 169774 Bromocriptine methanesulfonate 0.0339770934764516 0.3479483
NSC 254677 Phomazarin 0.0339770934764516 -0.30048032
Total:151  Current:114    [First] [Prev] [Next] [Last]